Scientists at The Hospital for Sick Children (SickKids) have identified a key gene that could lead to next-generation ...

Hyperkalemia, which can induce signs of a heart attack or paralysis and weakness of the muscles, is defined as a level that is higher than 5.0-5.5 mEq/L.

Researchers find blocking the KCNB2 gene can slow tumor growth, paving the way for next-gen treatments for childhood brain cancer.

SickKids researchers identified the KCNB2 gene as a key driver of medulloblastoma tumor growth. Blocking KCNB2 disrupts ...

Researchers find blocking the KCNB2 gene can slow tumour growth, paving the way for next-gen treatments for childhood brain cancer.

Scientists at The Hospital for Sick Children (SickKids) have identified a key gene that could lead to next-generation ...

Some tumor types spread throughout the body and develop metastases instead of staying at their original location.

In the next step, the researchers want to develop new molecules based on digoxin that are even better at dissolving the CTC clusters.

G Protein-Coupled Receptors (GPCRs): A large family of cell surface receptors that respond to various external signals and activate intracellular signaling pathways. Inward Rectifying Potassium ...

Certain tumor types do not remain at their point of origin but spread throughout the body and form metastases. This is ...

Scientists at The Hospital for Sick Children (SickKids) have identified a key gene that could lead to next-generation treatments for medulloblastoma, the most common malignant brain tumor in children.